MUC16 and ovarian carcinoma: In the clinical evaluation, the resulting optimized assay (CA125MGL) showed good discrimination between the samples of epithelial ovarian cancer patients and those with endometriosis, a condition that has decisively hampered the use of CA125 for early detection/screening of ovarian cancer.